Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone

Overview

Journal Neurocrit Care

Specialty Critical Care

Date 2019 Oct 2

PMID 31571175

Citations 1

Authors

Maximiliano A Hawkes

Alejandro A Hlavnicka

Nestor A Wainsztein

Affiliations

Soon will be listed here.

Citing Articles

Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.

Hadhiah K, Alshagawi Z, Alzahrani S, Alrayes M, Aldandan H Am J Case Rep. 2021; 22:e934528.

PMID: 34784343 PMC: 8607028. DOI: 10.12659/AJCR.934528.

References

Ducros A . Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012; 11(10):906-17. DOI: 10.1016/S1474-4422(12)70135-7. View

Cappelen-Smith C, Calic Z, Cordato D . Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment. Curr Treat Options Neurol. 2017; 19(6):21. DOI: 10.1007/s11940-017-0460-7. View

Purkayastha S, Sorond F . Transcranial Doppler ultrasound: technique and application. Semin Neurol. 2013; 32(4):411-20. PMC: 3902805. DOI: 10.1055/s-0032-1331812. View

Lazaridis C, Czosnyka M . Cerebral blood flow, brain tissue oxygen, and metabolic effects of decompressive craniectomy. Neurocrit Care. 2012; 16(3):478-84. DOI: 10.1007/s12028-012-9685-1. View

Nelson A, Blake D, Chen R . Digit-specific aberrations in the primary somatosensory cortex in Writer's cramp. Ann Neurol. 2009; 66(2):146-54. DOI: 10.1002/ana.21626. View

Ducros A, Hajj-Ali R, Singhal A, Wang S . Reversible cerebral vasoconstriction syndrome. JAMA Neurol. 2014; 71(3):368. DOI: 10.1001/jamaneurol.2013.5875. View

Sattar A, Manousakis G, Jensen M . Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther. 2010; 8(10):1417-21. PMC: 3020907. DOI: 10.1586/erc.10.124. View

Sorensen D . Reversible Cerebral Vasoconstriction Syndrome. JAMA Neurol. 2015; 73(2):232-3. DOI: 10.1001/jamaneurol.2015.3472. View

Singhal A, Topcuoglu M . Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2016; 88(3):228-236. PMC: 5272793. DOI: 10.1212/WNL.0000000000003510. View

10.

Singhal A, Hajj-Ali R, Topcuoglu M, Fok J, Bena J, Yang D . Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol. 2011; 68(8):1005-12. DOI: 10.1001/archneurol.2011.68. View

11.

Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser M . The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007; 130(Pt 12):3091-101. DOI: 10.1093/brain/awm256. View

12.

Chen S, Fuh J, Lirng J, Chang F, Wang S . Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder?. Neurology. 2006; 67(12):2164-9. DOI: 10.1212/01.wnl.0000249115.63436.6d. View

13.

Marsh E, Ziai W, Llinas R . The Need for a Rational Approach to Vasoconstrictive Syndromes: Transcranial Doppler and Calcium Channel Blockade in Reversible Cerebral Vasoconstriction Syndrome. Case Rep Neurol. 2016; 8(2):161-171. PMC: 5043170. DOI: 10.1159/000447626. View

14.

Calabrese L, Dodick D, Schwedt T, Singhal A . Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007; 146(1):34-44. DOI: 10.7326/0003-4819-146-1-200701020-00007. View

15.

Katz B, Fugate J, Ameriso S, Pujol-Lereis V, Mandrekar J, Flemming K . Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol. 2013; 71(1):68-73. DOI: 10.1001/jamaneurol.2013.4639. View

16.

Elstner M, Linn J, Muller-Schunk S, Straube A . Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine. Cephalalgia. 2009; 29(6):677-82. DOI: 10.1111/j.1468-2982.2008.01768.x. View

17.

Linn J, Fesl G, Ottomeyer C, Straube A, Dichgans M, Bruckmann H . Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases?. Cephalalgia. 2011; 31(10):1074-81. DOI: 10.1177/0333102410394673. View

18.

Bouchard M, Verreault S, Gariepy J, Dupre N . Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache. 2008; 49(1):142-5. DOI: 10.1111/j.1526-4610.2008.01211.x. View

19.

Song J, Fisher S, Seifert T, Cacayorin E, Alexandrov A, Malkoff M . Postpartum cerebral angiopathy: atypical features and treatment with intracranial balloon angioplasty. Neuroradiology. 2004; 46(12):1022-6. DOI: 10.1007/s00234-003-1129-3. View

20.

Al-Mufti F, Dodson V, Wajswol E, El-Ghanem M, Alchaki A, Nuoman R . Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome. Br J Neurosurg. 2018; 32(4):431-435. DOI: 10.1080/02688697.2018.1479512. View